id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-4669-0006,FDA,FDA-2015-E-4669,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2017-09-20T04:00:00Z,2017,9,2017-09-20T04:00:00Z,,2017-09-20T18:06:54Z,,0,0,0900006482b6401e
FDA-2015-E-4669-0005,FDA,FDA-2015-E-4669,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-12-08T05:00:00Z,2016,12,2016-12-08T05:00:00Z,,2016-12-08T16:20:20Z,,0,0,09000064823ede07
FDA-2015-E-4669-0004,FDA,FDA-2015-E-4669,Determination of Regulatory Review Period for Purposes of Patent  Extension; IXINITY,Notice,Determinations,2016-11-29T05:00:00Z,2016,11,2016-11-29T05:00:00Z,2017-05-31T03:59:59Z,2016-11-29T16:20:41Z,2016-28653,0,0,09000064823c693a
FDA-2015-E-4669-0003,FDA,FDA-2015-E-4669,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-03-16T04:00:00Z,2016,3,2016-03-16T04:00:00Z,,2016-03-16T19:16:26Z,,0,0,0900006481ec44be
FDA-2015-E-4669-0001,FDA,FDA-2015-E-4669,Patent Extension Application from Cooley LLP ( on behalf of The University of North Carolina at Chapel Hill ),Other,Application,2015-12-08T05:00:00Z,2015,12,2015-12-08T05:00:00Z,,2015-12-17T15:54:27Z,,0,0,0900006481d8e5d9
FDA-2015-E-4669-0002,FDA,FDA-2015-E-4669,Letter from U.S. Patent and Trademark Office to FDA,Other,Letter(s),2015-12-08T05:00:00Z,2015,12,2015-12-08T05:00:00Z,,2015-12-08T16:47:54Z,,0,0,0900006481d8e660